SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-17-002965
Filing Date
2017-03-29
Accepted
2017-03-29 15:42:57
Documents
14
Period of Report
2017-03-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 30660
2 ex99-1.htm EX-99.1 30864
3 ex99-2.htm EX-99.2 9773
4 ex99-2_001.jpg GRAPHIC 33053
5 ex99-2_002.jpg GRAPHIC 90547
6 ex99-2_003.jpg GRAPHIC 65671
7 ex99-2_004.jpg GRAPHIC 68844
8 ex99-2_005.jpg GRAPHIC 56135
9 ex99-2_006.jpg GRAPHIC 56150
10 ex99-2_007.jpg GRAPHIC 82133
11 ex99-2_008.jpg GRAPHIC 44155
12 ex99-2_009.jpg GRAPHIC 68545
13 ex99-2_010.jpg GRAPHIC 57402
14 ex99-2_011.jpg GRAPHIC 42042
  Complete submission text file 0001493152-17-002965.txt   989006
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37428 | Film No.: 17722127
SIC: 2834 Pharmaceutical Preparations